Abluminus - Model NP - Sirolimus Based Nano Carrier Eluting Stent System

Deals with the HARD facts with current DES

ABLUMINAL COATING
Drug is coated on the abluminal side only.
Leading to mono directional drug release & less systemic exposure of drug which leads to faster healing

FUSION COATING
Drug is coated on stent as well as exposed parts of balloon & coated on the proximal and distal ends.
Helps to address the entire disease area of lesion and address focal restenosis and edge restenosis.

POLYMER FREE NANO CARRIER DRUG DELIVERY
Designed for acute as well as sustained drug transfer in arterial wall – leading to less chronic inflammation and improved vascular healing.

POLYMER FREE COATING
Proposed the shorter DAPT which helps to reduced bleeding risk in patients with high bleeding risk

• Reduces drug dose
• Effective drug transfer to the deepest layer of the vessel
• Protect drug by encapsulation- reduced in-transit drug loss
• Better in-tissue bioavailability of dru

DRUG
Drug: Sirolimus
Drug Dose: 1.26 µg/mm²
Drug Carrier: Phospholipid

Stent
Stent Material: Cobalt Chromium Alloy L605
Strut Thickness: 73 µm
Strut Width: 80 µm (hinge) – 120 µm (strut)
Average Recoil: Less than 5%
Average Foreshortening: Less than 1% (Zero foreshortening design)

Delivery system
Delivery System: RX stent delivery system
Nominal Pressure: 8 bar
Rated Burst Pressure: 14 bar
Guide Wire Compatibility (max.): 0.014’’
Guiding Catheter Compatibility: 5F
Stent Diameter(mm): 2.25, 2.50, 2.75, 3.00, 3.50, 4.00
Stent Length(mm): 8, 12, 16, 20, 24, 28, 32, 36, 40